Bahr Nathan C, Antinori Spinello, Wheat L Joseph, Sarosi George A
Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA ; Department of Medicine, University of Minnesota, Minneapolis MN, USA.
Department of Clinical and Biomedical Sciences, "Luigi Sacco," III Division of Infectious Diseases, University of Milano, Milano, Italy.
Curr Trop Med Rep. 2015 Jun 1;2(2):70-80. doi: 10.1007/s40475-015-0044-0.
In the United States, histoplasmosis is generally thought to occur mainly in the Ohio and Mississippi River Valleys, and the classic map of histoplasmosis distribution reflecting this is second nature to many U.S. physicians. With the advent of the HIV pandemic reports of patients with progressive disseminated histoplasmosis and AIDS came from regions of known endemicity, as well as from regions not thought to be endemic for histoplasmosis throughout the world. In addition, our expanding armamentarium of immunosuppressive medications and biologics has increased the diagnosis of histoplasmosis worldwide. While our knowledge of areas in which histoplasmosis is endemic has improved, it is still incomplete. Our contention is that physicians should consider with the right constellations of symptoms in any febrile patient with immune suppression, regardless of geographic location or travel history.
在美国,组织胞浆菌病通常被认为主要发生在俄亥俄河和密西西比河流域,许多美国医生对反映这种情况的组织胞浆菌病分布经典地图都耳熟能详。随着艾滋病大流行的出现,关于播散性组织胞浆菌病患者和艾滋病患者的报告不仅来自已知的地方流行区,也来自世界各地原本不被认为是组织胞浆菌病地方流行区。此外,我们不断扩充的免疫抑制药物和生物制剂增加了全球范围内组织胞浆菌病的诊断率。虽然我们对组织胞浆菌病地方流行区域的了解有所改善,但仍然不完整。我们的观点是,医生应该考虑对任何有免疫抑制的发热患者,无论其地理位置或旅行史如何,只要有合适的症状组合,都要考虑到组织胞浆菌病。